Splenic diffuse red pulp lymphoma has a distinct pattern of somatic mutations amongst B-cell malignancies

Leukemia and Lymphoma

Volumn 58, Issue 3, 2017, Pages 666-675

  Traverse Glehen, Alexandra ^a,b   Verney, Aurélie ^b   Gazzo, Sophie ^b,c   Jallades, Laurent ^b,c   Chabane, Kaddour ^b,c   Hayette, Sandrine ^b,c   Coiffier, Bertrand ^b,c   Callet Bauchu, Evelyne ^b,c   Ffrench, Martine ^c   Felman, Pascale ^b,c   Berger, Françoise ^a,b   Baseggio, Lucile ^b,c   Salles, Gilles ^b,c  

^a HOSPICES CIVILS DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

^c CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

BRAF; IGHV; MYD88; NOTCH2; splenic diffuse red pulp lymphoma; splenic lymphoma

Indexed keywords

B RAF KINASE; BIOLOGICAL MARKER; CD180 ANTIGEN; CD5 ANTIGEN; CYCLIN D1; GENOMIC DNA; LEUKOSIALIN; LIPOCORTIN 1; MYELOID DIFFERENTIATION FACTOR 88; NOTCH2 RECEPTOR; PROTEIN P53; TRANSCRIPTION FACTOR SOX11; UNCLASSIFIED DRUG; CD180 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; TUMOR MARKER;

ADULT; ANEMIA; ARTICLE; B CELL LYMPHOMA; CD3+ T LYMPHOCYTE; CHROMOSOME ANALYSIS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN HEAVY CHAIN GENE; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SOMATIC MUTATION; SPLENIC DIFFUSE RED PULP LYMPHOMA; SPLENOMEGALY; AGED; CANCER STAGING; CHROMOSOME ABERRATION; DNA MUTATIONAL ANALYSIS; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC PREDISPOSITION; GENETICS; IMMUNOHISTOCHEMISTRY; LYMPH NODE; METABOLISM; MIDDLE AGED; MUTATION; PATHOLOGY; RETROSPECTIVE STUDY; SPLEEN TUMOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIGENS, CD; BIOMARKERS, TUMOR; CHROMOSOME ABERRATIONS; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPH NODES; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; MUTATION; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SPLENIC NEOPLASMS;

EID: 84976320163     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428194.2016.1196813     Document Type: Article

References (25)

1. Traverse-Glehen A, Baseggio L, Bauchu EC, et al. Splenic red pulp lymphoma with numerous basophilic villous lymphocytes:a distinct clinicopathologic and molecular entity? Blood. 2008;111:2253–2260.
2. Kanellis G, Mollejo M, Montes-Moreno S, et al. Splenic diffuse red pulp small B-cell lymphoma:revision of a series of cases reveals characteristic clinico-pathological features. Haematologica. 2010;95:1122–1129.
3. S, Swerdlow E, Campo NL., Harris, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 2nd ed. Lyon:WHO, International Agency for Research on Cancer; 2008.
4. Tiacci E, Trifonov V, Schiavoni G, et al. BRAF mutations in hairy-cell leukemia. N Engl J Med. 2011;364:2305–2315.
5. Kiel MJ, Velusamy T, Betz BL, et al. Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma. J Exp Med. 2012;209:1553–1565.
6. Treon SP, Xu L, Yang G, et al. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia. N Engl J Med. 2012;367:826–833.
7. Miguet L, Lennon S, Baseggio L, et al. Cell-surface expression of the TLR homolog CD180 in circulating cells from splenic and nodal marginal zone lymphomas. Leukemia. 2013;27:1748–1750.
8. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949–954.
9. Rossi D, Trifonov V, Fangazio M, et al. The coding genome of splenic marginal zone lymphoma:activation of NOTCH2 and other pathways regulating marginal zone development. J Exp Med. 2012;209:1537–1551.
10. Traverse-Glehen A, Davi F, Ben Simon E, et al. Analysis of VH genes in marginal zone lymphoma reveals marked heterogeneity between splenic and nodal tumors and suggests the existence of clonal selection. Haematologica. 2005;90:470–478.
11. Bikos V, Darzentas N, Hadzidimitriou A, et al. Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene:ontogenetic implications. Leukemia. 2012;26:1638–1646.
12. Baseggio L, Traverse-Glehen A, Callet-Bauchu E, et al. Relevance of a scoring system including CD11c expression in the identification of splenic diffuse red pulp small B-cell lymphoma (SRPL). Hematol Oncol. 2011;29:47–51.
13. Callet-Bauchu E, Baseggio L, Felman P, et al. Cytogenetic analysis delineates a spectrum of chromosomal changes that can distinguish non-MALT marginal zone B-cell lymphomas among mature B-cell entities:a description of 103 cases. Leukemia. 2005;19:1818–1823.
14. Evans PA, Pott C, Groenen PJTA, et al. Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia. 2007;21:207–214.
15. Ponzoni M, Kanellis G, Pouliou E, et al. Bone marrow histopathology in the diagnostic evaluation of splenic marginal-zone and splenic diffuse r–ed pulp small B-cell lymphoma:a reliable substitute for spleen histopathology? Am J Surg Pathol. 2012;36:1609–1618.
16. Mendes LST, Attygalle A, Matutes E, et al. Annexin A1 expression in a splenic diffuse red pulp small B-cell lymphoma:report of the first case. Histopathology. 2013;63:590–593.
17. Krenács L, Tóth-Lipták J, Demeter J, et al. Monoclonal antibody HBME-1 reacts with a minor subset of B cells with villous surface and can be useful in the diagnosis of hairy cell leukemia and other indolent lymphoproliferations of villous B lymphocytes. Virchows Arch Int J Pathol. 2013;463:787–794.
18. Martinez D, Navarro A, Martinez-Trillos A, et al. NOTCH1, TP53, and MAP2K1 mutations in splenic diffuse red pulp small B-cell lymphoma are associated with progressive disease. Am J Surg Pathol. 2016;40:192–201.
19. Mollejo M, Algara P, Mateo MS, et al. Splenic small B-cell lymphoma with predominant red pulp involvement:a diffuse variant of splenic marginal zone lymphoma? Histopathology. 2002;40:22–30.
20. Traverse-Glehen A, Baseggio L, Salles G, et al. Splenic marginal zone B-cell lymphoma:a distinct clinicopathological and molecular entity. Curr Opin Oncol. 2011;23:441–448.
21. Traverse-Glehen A, Bachy E, Baseggio L, et al. Immunoarchitectural patterns in splenic marginal zone lymphoma:correlations with chromosomal aberrations, IGHV mutations, and survival. A study of 76 cases. Histopathology. 2013;62:876–893.
22. Basso K, Liso A, Tiacci E, et al. Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptors. J Exp Med. 2004;199:59–68.
23. Raess PW, Mintzer D, Husson M, et al. BRAF V600E is also seen in unclassifiable splenic B-cell lymphoma/leukemia, a potential mimic of hairy cell leukemia. Blood. 2013;122:3084–3085.
24. Hockley SL, Else M, Morilla A, et al. The prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphoma. Br J Haematol. 2012;158:347–354.
25. Matutes E, Wotherspoon A, Brito-Babapulle V, et al. The natural history and clinico-pathological features of the variant form of hairy cell leukemia. Leukemia. 2001;15:184–186.